Dr. Idris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Koch Institute for Integrative Cancer Research, MIT
500 Main Street
Cambridge, MA 02142- Is this information wrong?
Summary
- Immunologist and Pediatric Infectious Disease specialist with extensive research and clinical experience committed to medical application of science discovery to alleviate suffering in developing countries.
Education & Training
- Children's National Medical Center/George Washington UniversityFellowship, Pediatric Infectious Diseases, 2013 - 2015
- Emory University School of MedicineResidency, Pediatrics, 2001 - 2004
- Icahn School of Medicine at Mount SinaiClass of 2001
- Mount Sinai School of MedicinePh.D., Immunology, 1999
- Massachusetts Institute of TechnologyB.Sc., Biology, 1987 - 1991
Certifications & Licensure
- MA State Medical License 2020 - 2025
- DC State Medical License 2013 - 2022
- VA State Medical License 2007 - 2016
- GA State Medical License 2003 - 2009
- FL State Medical License 2004 - 2008
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- The Wandra L. Jones-Phillips Compassionate Caregiver Award Emory University Division of Neonatology, 2003
- Jeffery Modell Prize for Excellence in Immunology Mount Sinai School of Medicine, 2001
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- 1 citationsLack of affinity signature for germinal center cells that have initiated plasma cell differentiation.Sutton, H., Gao, X., Kelly, H., Parker, B., Lofgren, M., Dacon, C., Chatterjee, D., Seder, R., Tan, J., Neeman, T., Cockburn, I., Idris, A.> ;Immunity. 2024 Feb 13
- 2 citationsCytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection.Manuela C Aguirre-Botero, Lawrence T Wang, Pauline Formaglio, Eduardo Aliprandini, Jean-Michel Thiberge, Arne Schön, Yevel Flores-Garcia, Shamika Mathis-Torres, Barbar...> ;Cell Reports. 2023 Jul 25
- 2 citationsCryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope.Prabhanshu Tripathi, Michael F Bender, Haotian Lei, Lais Da Silva Pereira, Chen-Hsiang Shen, Brian Bonilla, Marlon Dillon, Li Ou, Marie Pancera, Lawrence T Wang, Baosh...> ;Structure. 2023 Apr 6
- Join now to see all
Journal Articles
- Murine natural killer cell activation receptorsSmith HR, Idris AH, Yokoyama WM, Immunol Rev, 1/1/2001
- The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killingIdris AH, Smith HR, Mason LH, Ortaldo JR, Scalzo AA, Yokoyama WM, Proc Natl Acad Sci U S A, 1/1/1999
- Close genetic linkage of Chok with the NKC-linked loci Cd94, Ly49, and Cmv1 on mouse chromosome 6Idris AH, Scalzo AA, Yokoyama WM, Immunogenetics, 1/1/1999
- Join now to see all
Abstracts/Posters
- Identification of the Chok gene product that regulates natural killing.Idris AH, Smith HRC, Ortaldo JR, Scalzo AA, Yokoyama, WM, FASEB J, FASEB, ASBMB/ASIP/AAI Joint Meeting, Washington, DC, 1/17/1999
- A genetic locus controlling tumor killing maps to the NKC.Idris AH, Scalzo AA, Yokoyama, WM, J Allergy Clin Immunol, AAAI, AAI, CIS Joint Meeting, San Francisco, CA, 1/21/1997
- Genetically determined capacity of natural killer cells to lyse tumor targets.Idris AH, Yokoyama, WM, FASEB J, New Orleans, LA, 1/2/1996
Professional Memberships
- Fellow
Other Languages
- Arabic
Hospital Affiliations
- NIH Clinical CenterBethesda, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: